UTHR FY 2023 Earnings — United Therapeutics Corporation Revenue & Financial Results | Market Cap Arena

UTHRUnited Therapeutics Corporation

$24B

FY 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$2.3B+20.2% YoY

Gross Profit

$2.1B88.9% margin

Operating Income

$1.2B50.9% margin

Net Income

$985M42.3% margin

EPS (Diluted)

$19.81

Cash Flow

Operating Cash Flow

$978M

Free Cash Flow

$748M

Stock-Based Comp.

$39M

Balance Sheet

Total Assets

$7.2B

Total Liabilities

$1.2B

Stockholders' Equity

$6.0B

Cash & Equivalents

$1.2B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$2.3B	$1.9B	+20.2%
Gross Profit	$2.1B	$1.8B	+15.7%
Operating Income	$1.2B	$980M	+20.9%
Net Income	$985M	$727M	+35.4%